Wakamoto Pharmaceutical (4512.T) Earnings Analysis
Wakamoto Pharmaceutical (4512.T) has no confirmed upcoming earnings date. Trailing P/E 41.53.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 4512.T next report earnings?
No confirmed upcoming earnings date is currently scheduled for 4512.T. This page updates as the calendar is published.
4512.T earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-15 | 0.35 JPY | n/a | n/a | n/a |
| 2026-02-04 | 10.05 JPY | n/a | n/a | n/a |
| 2025-11-06 | -0.74 JPY | n/a | n/a | n/a |
| 2025-05-15 | 2.4 JPY | n/a | n/a | n/a |
| 2025-02-05 | 3.53 JPY | n/a | n/a | n/a |
| 2024-08-02 | -0.32 JPY | n/a | n/a | n/a |
4512.T valuation and analyst view
| Trailing P/E | 41.53 |
|---|---|
| Trailing EPS | 6.546 JPY |
| Price / book | 0.79 |
| Dividend yield | 1.29% |
| Market cap | 9.51B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Wakamoto Pharmaceutical (4512.T)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for 4512.T. This page updates as the calendar is published.
Did 4512.T beat earnings last quarter?
Consensus estimate data was not available for 4512.T's 2026-05-15 report.
What is 4512.T's current P/E ratio and EPS?
4512.T trades at a trailing P/E of 41.53 on trailing EPS of 6.5464734355191885 JPY.
What do analysts rate 4512.T?
4512.T has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.